Does inflammatory dental disease affect the development of medication-related osteonecrosis of the jaw in patients using high-dose bone-modifying agents?-Reference-Cited by-同舟云学术

Does inflammatory dental disease affect the development of medication-related osteonecrosis of the jaw in patients using high-dose bone-modifying agents?

Published:2020-10-14 Issue:5 Volume:25 Page:3087-3093
ISSN:1432-6981
Container-title:Clinical Oral Investigations
language:en
Short-container-title:Clin Oral Invest

Author:

Ueda Nobuhiro^ORCID,Nakashima Chie,Aoki Kumiko,Shimotsuji Hiroko,Nakaue Kazuhiko,Yoshioka Hajime,Kurokawa Satoshi,Imai Yuichiro,Kirita Tadaaki

Publisher

Springer Science and Business Media LLC

Subject

General Dentistry

Link

https://link.springer.com/content/pdf/10.1007/s00784-020-03632-7.pdf

Reference26 articles.

1. Berenson JR, Rajdev L, Broder M (2006) Treatment strategies for skeletal complications of cancer. Cancer Biol Ther 5:1074–1077. https://doi.org/10.4161/cbt.5.9.3305

2. Fizazi K, Carducci M, Smith M, Damião R, Brown J, Karsh L, Milecki P, Shore N, Rader M, Wang H, Jiang Q (2011) Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet 377:813–822. https://doi.org/10.1016/S0140-6736(10)62344-6

3. Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115–1117. https://doi.org/10.1016/s0278-2391(03)00720-1

4. Ruggiero S, Gralow J, Marx RE, Hoff AO, Schubert MM, Huryn JM, Toth B, Damato K, Valero V (2006) Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract 2:7–14. https://doi.org/10.1200/JOP.2006.2.1.7

5. Yoneda T, Hagino H, Sugimoto T, Ohta H, Takahashi S, Soen S, Taguchi A, Toyosawa S, Nagata T, Urade M (2010) Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology and Japanese Society of Oral and Maxillofacial Surgeons. J Bone Miner Metab 28:365–383. https://doi.org/10.1007/s00774-010-0162-7

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precursor Radiographic Findings in Patients With Medication-Related Osteonecrosis of the Jaw;Journal of Oral and Maxillofacial Surgery;2024-08

2. Risk factors for dental findings of the development of medication-related osteonecrosis of the jaw: Investigation of 3734 teeth in cancer patients receiving high dose antiresorptive agents;Journal of Dental Sciences;2024-01

3. Measurement of Thickness at the Inferior Border of the Mandible Using Computed Tomography Images: A Retrospective Study including 300 Japanese Cases;Tomography;2023-06-22

4. Comparison of Different Antibiotic Regimes for Preventive Tooth Extractions in Patients with Antiresorptive Intake—A Retrospective Cohort Study;Antibiotics;2023-06-01

5. A systematic review assessing occurrence of medication-related osteonecrosis of the jaw following dental procedures;Brazilian Journal of Oral Sciences;2022-08-22